Floatz logo

Therapeutic Asset Ratings

13,145 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Liafensine
Major Depressive Disorder
Denovo Biopharma LLCP2B (57)
Linezolid
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Linezolid
Cancer
M.D. Anderson Cancer CenterP2B (57)
Lisinopril
Breast Cancer
UNC Lineberger Comprehensive Cancer CenterP2B (57)
Lithium, Elemental
Classic Familial Adenomatous Polyposis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)P2B (57)
Lopinavir
Cancer
DualityBio Inc.P2B (57)
Lorigerlimab
Prostate Cancer
MacroGenicsP2B (57)
Lornoxicam
B-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow UniversityP2B (57)
Losartan
Chemotherapy-Induced Neuropathy
Future University in EgyptP2B (57)
Lum-201
Metabolic Dysfunction-Associated Steatotic Liver Disease
Massachusetts General HospitalP2B (57)
Lum-201
Metabolic Dysfunction-Associated Steatohepatitis
Massachusetts General HospitalP2B (57)
Lurasidone
Mood Disorder
First Affiliated Hospital of Zhejiang UniversityP2B (57)
Mangafodipir Trisodium
Diastolic Heart Failure
IC TARGETS ASP2B (57)
Mannitol
Anaplastic Astrocytoma
Northwell HealthP2B (57)
Mannitol
Brain Cancer
Northwell HealthP2B (57)
Mannitol
Brain Neoplasm
Northwell HealthP2B (57)
Mannitol
Glioblastoma
Northwell HealthP2B (57)
Marcaine
Breast Disorder
Beni-Suef UniversityP2B (57)
Maridebart Cafraglutide
Type 2 Diabetes Mellitus
AmgenP2B (57)
Melatonin
Amyotrophic Lateral Sclerosis
Duke UniversityP2B (57)
Melatonin
Breast Carcinoma
Tanta UniversityP2B (57)
Melatonin
Hypersomnia
Duke UniversityP2B (57)
Melphalan
Acute Myeloid Leukemia With Multilineage Dysplasia
National Cancer Institute (NCI)P2B (57)
Melphalan
Acute Myeloid Leukemia With 11q23 Abnormalities
M.D. Anderson Cancer CenterP2B (57)
Melphalan
Angioimmunoblastic T-Cell Lymphoma
Eric Jacobsen, MDP2B (57)
Showing 3226 to 3250 of 13,145 assets
PreviousPage 130 of 526Next